Pulmonary hypertension in eosinophilic <i>versus</i> noneosinophilic COPD.

ERJ Open Res · 2021 · PMC7938054 · PMID 33718496

Europe PMC DOI

hedged sentence

0.0870

closest p · 1.7× alpha

0.0870

boldest claim

The sentences

did not reach statistical significancep=0.087so close (0.05 < p ≤ 0.1)

Roflumilast use was more common in the eosinophilic COPD group, but did not reach statistical significance (23% versus 10%, p=0.087).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.